Patient-Derived Organoid Models

Laboratory models simulating cellular and organ conditions for research purposes in cell biology and tissue engineering studies.

A three-dimensional in vitro cell culture system that establishes patient-derived tumor organoid models highly similar to patient tumor characteristics. The tumor organoids maintain high consistency with patient tumor pathological, molecular, and genetic features while enabling personalized drug sensitivity assessment, with reported accuracy up to 80%.

Cancer organoid growth kit utilizing organ-on-chip technology to create high-fidelity human tissue models for drug efficacy evaluation and clinical treatment planning. Enables personalized medicine through rapid assessment of therapeutic response and toxicity in cancer research and oncology applications.

Induced pluripotent stem cells generated from human biospecimens for research and therapeutic development. These cells enable generation of patient-derived tumor organoids and xenografts, development of personalized treatment models, and advanced disease modeling.

A biobank repository containing renewable primary cancer cells sourced from patient samples. This resource provides authentic tumor cell models for drug testing, molecular profiling, and precision oncology research.

An organ-on-chip platform specifically designed for pharmaceutical and biotech drug development and testing. Combines 3D human tissue models with dynamic flow simulation to predict drug efficacy and safety in clinically relevant conditions.

An organ-on-chip technology platform that combines clinically relevant tissue size with independent millifluidic environments and fully controlled fluid flow. Enables 3D humanized tissue models with dynamic flow environments to mimic physiological conditions for in vitro testing and research.

Specialized platform for sorting and isolating 3D cellular models and organoids. Supports advanced cellular model development and characterization. Enables precision handling of complex three-dimensional biological structures.

Microfluidic platforms designed for high-throughput organoid, spheroid and organ-on-chip culturing and analysis. These systems enable controlled environments for advanced biological research and drug development.

Advanced microfluidic organ-on-a-chip devices that model human organ functions for drug testing and disease research. These systems provide realistic biological microenvironments for preclinical evaluation of therapeutics.

Specialized microfluidic organ-on-chip platforms for in vitro tissue modeling and drug testing in biomedical research.

Microfluidic platforms specifically designed for high-throughput organoid, spheroid, and organ-on-chip culturing and analysis. These systems provide controlled biological environments for advanced research and drug development applications.